HALO logo
halo search icon
Organon & Co.
Organon & Co.
OGN · NYS

Organon & Co.

US$13.46

Price Arrow0.04 (0.298%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakupFakey Shakey - ShortFakey Shakey - Short (Realtime)HALO AllHALO Capital EfficiencyHALO GARP+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Organon & Co. Overview

OGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Neutral

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About OGN

icon

Website

Organon & Co.

icon

Telephone

1.551.430.6900

icon

Address

33rd floor, 30 Hudson Street, Jersey City, NJ 07302

Description

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

OGN Price Chart

Key Stats

Market Cap

US$3.52B

PE

10.00

EV/EBITDA

6.1

Dividends Overview

DIV Yield

4.7%

Franking

N/A

Ex Dividend Date (est.)

11-May-26

Market Data

52 weeks range

Low 5.69 - 13.47

Trade Value (12mth)

US$14,062,614.00

1 week

0.15%

1 month

51.81%

YTD

85.36%

1 year

59.19%

All time high

39.47

Key Fundamentals

EPS 3 yr Growth

-80.00%

EBITDA Margin

26.30%

Operating Cashflow

$700m

Free Cash Flow Return

7.40%

ROIC

2.00%

Interest Coverage

3.20

Quick Ratio

1.20

Other Data

Shares Outstanding (Fully Diluted)

263m

HALO Sector

Healthcare

Next Company Report Date

18-Feb-27

Next Ex Dividend Date

11-May-26

Next Dividend Pay Date

11-Jun-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

OGN Announcements

Latest Announcements

DateAnnouncements
04 May 26
30 April 26
30 April 26
27 April 26
27 April 26

OGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock4.013.360.72locklocklock
EPS (Fully Diluted)
$locklocklocklock3.993.330.72locklocklock
Growth
%locklocklocklock11.1-16.1-78.6locklocklock
PE
Xlocklocklocklock3.64.510locklocklock
EV/EBITDA
Xlocklocklocklock7.56.86.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

11-May-26

DIV Yield

4.7%

Franking Level

N/A

DPSg

-69.6%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Organon & Co. (OGN:NYS)?
Halo FAQ
The current share price of Organon & Co. (OGN:NYS) is USD$13.46.
What is the 52-week high share price for Organon & Co. (OGN:NYS)?
Halo FAQ
The 52-week high share price for Organon & Co. (OGN:NYS) is USD$13.47.
What is the 52-week low share price for Organon & Co. (OGN:NYS)?
Halo FAQ
The 52-week low share price for Organon & Co. (OGN:NYS) is USD$5.69.
What is the dividend yield for Organon & Co. (OGN:NYS)?
Halo FAQ
The current TTM dividend payout for Organon & Co. (OGN:NYS) is 4.70.
What was Organon & Co. (OGN:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Organon & Co. (OGN:NYS) is USD$0.02.
What is the franking level for Organon & Co. (OGN:NYS)?
Halo FAQ
Organon & Co. (OGN:NYS) has a franking level of 0.00%.
In which sector is Organon & Co. (OGN:NYS) classified?
Halo FAQ
Organon & Co. (OGN:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Organon & Co. (OGN:NYS)?
Halo FAQ
The current P/E ratio for Organon & Co. (OGN:NYS) is 10.00.

See beyond the curve.

One solution for research, investing and portfolio management.